Perez-Iglesias, Rocio <br/><br/>
Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.  [electronic resource] 

 -  Journal of clinical psychopharmacology  Dec 2010 
 - 661-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-712X 
<br/><br/><label>Standard No.: </label>10.1097/jcp.0b013e3181fae248  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--genetics<br/>Adult<br/>Alpha-Ketoglutarate-Dependent Dioxygenase FTO<br/>Antipsychotic Agents--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Genetic Predisposition to Disease<br/>Genotype<br/>Humans<br/>Leptin--genetics<br/>Longitudinal Studies<br/>Male<br/>Polymorphism, Single Nucleotide<br/>Prospective Studies<br/>Proteins--genetics<br/>Psychotic Disorders--drug therapy<br/>Receptors, Leptin--genetics<br/>Schizophrenia--drug therapy<br/>Weight Gain--drug effects<br/>Young Adult